2018
DOI: 10.1016/j.chroma.2018.02.041
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic study of methylstenbolone in horses using liquid chromatography-high resolution mass spectrometry and gas chromatography-mass spectrometry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(15 citation statements)
references
References 22 publications
3
12
0
Order By: Relevance
“…Comparing the order of elution and mass spectra, the herein observed metabolites 14 and 18 were assigned to urinary metabolites of methylstenbolone reported by Calvacanti et al Unfortunately, applying a similar approach concerning the numerous metabolites identified in the horse proved considerably more complex as the gas chromatographic conditions differed substantially and the majority of the metabolites was discussed based on liquid chromatography‐mass spectrometry‐derived data . With a distinct loss of 103 Da under EI‐MS conditions, one metabolite (number 5 in Table ) showed similar features to the metabolite M1c tentatively characterized as 20‐hydroxymethylstenbolone by Choi et al After close scrutiny of the corresponding mass spectrum of metabolite 5, however, the structure of 20‐hydroxymethylstenbolone was not confirmed in the present study as depicted in Figure . For both the deuterated and the non‐deuterated metabolite, the characteristic fragment at m/z 143.0886 representing a diagnostic D‐ring fragment composed of carbons C‐15‐17 and C‐20 plus the O‐TMS moiety is still present, which precludes an additional hydroxyl group at C‐20 .…”
Section: Resultssupporting
confidence: 55%
See 3 more Smart Citations
“…Comparing the order of elution and mass spectra, the herein observed metabolites 14 and 18 were assigned to urinary metabolites of methylstenbolone reported by Calvacanti et al Unfortunately, applying a similar approach concerning the numerous metabolites identified in the horse proved considerably more complex as the gas chromatographic conditions differed substantially and the majority of the metabolites was discussed based on liquid chromatography‐mass spectrometry‐derived data . With a distinct loss of 103 Da under EI‐MS conditions, one metabolite (number 5 in Table ) showed similar features to the metabolite M1c tentatively characterized as 20‐hydroxymethylstenbolone by Choi et al After close scrutiny of the corresponding mass spectrum of metabolite 5, however, the structure of 20‐hydroxymethylstenbolone was not confirmed in the present study as depicted in Figure . For both the deuterated and the non‐deuterated metabolite, the characteristic fragment at m/z 143.0886 representing a diagnostic D‐ring fragment composed of carbons C‐15‐17 and C‐20 plus the O‐TMS moiety is still present, which precludes an additional hydroxyl group at C‐20 .…”
Section: Resultssupporting
confidence: 55%
“…The accurate mass of m/z 464.3457 corresponds to the elemental composition of C 27 H 48 2 H 2 O 2 Si 2 (mass error = 2.7 ppm) and besides the consecutive losses of a methyl radical (15 u) and the TMSOH (90 u), a characteristic loss of C 3 H 6 2 H (44 u) is observed. In the publication of Choi et al, methasterone is described as one metabolite of methylstenbolone in the equine . An initial comparison of the mass spectra obtained for methasterone and the new long‐term metabolites yielded similar fragments, but the comparison of the methasterone certified reference material and both the metabolites resulted in differing retention times under the described chromatographic conditions.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…a) contains a group of ions at m/z 179, 181, 194 (base peak), 195 and 206–208. Their relative abundances vary in corresponding 3‐TMSO‐Δ 1,3 ‐steroids depending on the substituent at C17 (enolized 17‐oxo (Parr et al, ; Schänzer & Donike, ) and in the spectra of various anabolic steroids with methyl groups at C2 or C17 (Choi et al, ) suggesting multiple fragmentation pathways. D 9 ‐TMS labeling showed the presence of an intact TMS group in these ions (Massé et al, ).…”
Section: Trimethylsilyl Derivativesmentioning
confidence: 99%